Lucid Diagnostics Inc. (LUCD)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, Lucid Diagnostics Inc. reported revenue of $4.71M, up 8.3% from the prior year. The company ran a net loss, with a net margin of -1232.7%. It held $40.45M in total assets against $29.51M in total liabilities.
Key ratios (FY2025)
-1054.8%
Operating margin
-1232.7%
Net margin
-530.4%
Return on equity
+8.3%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $4.71M | $4.35M | — | — | — | — | — |
| Cost of Revenue | $6.67M | $7.10M | — | — | $585.0K | — | — |
| Gross Profit | — | — | — | $377.0K | $500.0K | — | — |
| Operating Income | -$49.64M | -$46.05M | -$48.48M | -$56.25M | -$27.42M | -$8.28M | — |
| Net Income | -$58.01M | -$45.53M | -$52.67M | -$56.17M | -$28.08M | -$8.28M | — |
| EPS (Diluted) | $-0.69 | $-1.05 | $-1.26 | $-1.55 | $-1.51 | — | — |
| Total Assets | $40.45M | $30.71M | $27.27M | $32.51M | $59.00M | $2.19M | — |
| Total Liabilities | $29.51M | $25.32M | $29.58M | $9.46M | $4.26M | $15.71M | — |
| Shareholders' Equity | $10.94M | $5.39M | -$2.31M | $23.05M | $54.74M | -$13.52M | -$5.31M |
| Cash & Equivalents | — | $22.36M | $18.90M | $22.47M | $53.66M | — | — |
| Operating Cash Flow | -$46.48M | -$44.14M | -$32.82M | -$29.68M | -$17.67M | -$5.63M | — |
| Capital Expenditures | $197.0K | $296.0K | — | $3.20M | $862.0K | — | — |
| Shares Outstanding | 131.10M | 63.07M | 42.33M | 40.52M | 34.92M | 14.11M | — |